GSEA analysis revealed that low NR2E3 expression in HCC patients was associated with a heightened activation of the Wnt/β‐catenin signaling pathway and, notably, reduced NR2E3 expression extended beyond liver tumors, as we observed similar decreases in other tumor types compared to normal tissues. The gene discussed is NR2E3; the disease is hepatocellular carcinoma.